JASON ENGLAND: Open Payments
NPI 1861821985 · KENNEWICK, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 24 payments from 10 companies in 2025. Trend: 2023 $29 · 2024 $535 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $183 |
| Corcept Therapeutics | 1 | $105 |
| Otsuka America Pharmaceutical, Inc. | 1 | $87 |
| Daiichi Sankyo Inc. | 1 | $80 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| Lilly USA, LLC | 2 | $60 |
| ABBVIE INC. | 2 | $47 |
| Novo Nordisk Inc | 2 | $42 |
| Exact Sciences Corporation | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: NURTEC ODT, Korlym, REXULTI, INJECTAFER, MOUNJARO, UBRELVY, Wegovy, Cologuard Collection Kit.
Industry payments across WA — which companies pay providers there.
